Otsuka Pharmaceutical Archives - DelveInsight

Otsuka Pharmaceutical

Bipolar Depression Market |Bipolar Depression Pipeline
Watch Out For Top Pipeline Therapies Making An Impact In The Bipolar Depression Market

Characterized by debilitating episodes of depression and mood elevation (mania or hypomania), Bipolar depression is an under-recognized and unappreciated phase of bipolar disorder. Since most pati...


Alzheimer’s Disease Market | Biogen | Aducanumab | Eisai| Biogen | Aducanumab | Eisai |
Can Aducanumab Slove the Puzzle Of Alzheimer’s?

Alzheimer's Disease Market finally witnessed the approval of standard therapy, Aducanumab, by Biogen. What impact does it hold for the future? Demographic or population ageing is a global and d...


Alzheimer’s-Disease-Market-Scenario
An Ageing Population and Upcoming Therapies: What is shaping the Alzheimer’s Disease Market Scena...

The ageing population is a global phenomenon. According to the UN’s “World Population Prospects 2019” by 2100, the world’s population is projected to reach approximately 10.9 billion. Moreover, be...


Bipolar disorder market
Increasing cases of Mania and Bipolar disorder market

Bipolar Disorder is characterized by frequent-shifts in the mood and is a manic-depressive disorder hampering the routine life of an individual. According to the American Psychiatric Association, ...


Pharma News
Helsinn out licenses Pracinostat in South America

Helsinn Group grants exclusive licensing rights to Blanver and Varifarma for its leading drug Pracinostat in South America. Helsinn is a Swiss biopharmaceutical company committed to producing ...


Digital Pills
Digital Pill: A new frontier in digital healthcare all set to take-off

A digital pill is a tablet or capsule with embedded indigestible sensors that communicate about data outcomes related to when the medication is taken to a mobile application for access by the patie...


Editor's Pick
22 Healthcare Trends & Innovations to Watch in 2022 and Beyond

With the advent of new-age healthcare industry trends that are evident as of now, there...

Assessment of Key Products that Got FDA Approval in Second Half (H2) of 2021

Although COVID-19 continued to dominate headlines in 2021, pharmaceutical companies did...

Analyzing the Key Trends Driving the Biosimilar Market Growth

The Biosimilars market is growing at a breakneck pace. The biosimilar market provides a...

CAR-T Cell Therapy aka Miraculous Technology: Mapping the Market, Approved Th...

Chimeric antigen receptor T-cell (CAR T) therapies are shown to have transformative pot...

Myelodysplastic Syndromes (MDS): Key Pharma Players Unveiling Updated Finding...

There has been limited progress in the approval of novel agents in MDS. It has been a l...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.